Surfix Diagnostics, NKI and CRCbioscreen join forces to validate biomarkers for colorectal cancer screening
Globally, colorectal cancer impacts 1.9 million people each year, standing as a leading cause of cancer mortality
Globally, colorectal cancer impacts 1.9 million people each year, standing as a leading cause of cancer mortality
The project aims at screening the general health condition of the students enrolled in classes 6th to 12th.
First of its kind screening for Glaucoma at grass root level over 10k screened already
PredOmix has developed a novel blood test that can detect about 32 cancers in both men and women with 98 percent accuracy
The initiative launched in 2019 has touched over 10,000 lives with 500+ screening camps and aims to double its reach in the next 2 years
Biocon Foundation has pioneered a mHealth-technology-based (mobile health) oral cancer screening program in India
Passengers arriving from 6 high-risk countries are now mandatorily required to upload their negative RT-PCR test
In the next six months, the program aims to screen 4,000 women from underprivileged communities in and around Mathura
Colorectal Cancer Screening is now translated into multiple languages to help people worldwide understand why, when and how to screen for colorectal cancer
It is a point-of-care portable, battery-operated, IoT-enabled platform with a sample to result in less than 1 hour
Subscribe To Our Newsletter & Stay Updated